CLINICAL_TRIALS
trial_result
· 2019-09-13
Clinical Trial Update: Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in China
Summary
A completed real-world outcome study evaluating adalimumab in Chinese patients with rheumatoid arthritis, with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AbbVie | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2019-09-13